Clinical Trial Update: Endogenous Renin-Angiotensin-Aldosterone System and Glucose Metabolism [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining the endogenous renin-angiotensin-aldosterone system and glucose metabolism in metabolic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Metabolic Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2020-12-31